Literature DB >> 13597741

Clinical use of the biguanides and their role in stabilizing juvenile-type diabetes.

L P KRALL, P WHITE, R F BRADLEY.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13597741     DOI: 10.2337/diab.7.6.468

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  8 in total

1.  Oral hypoglycaemic agents in the treatment of diabetes mellitus.

Authors:  A LOUBATIERES
Journal:  Proc R Soc Med       Date:  1960-08

2.  [On the determination of insulin in the blood through the epididymal fat accumulation of the rat with aid of labelled glucose. III. The effect of sulfonylurea and biguanide (DBI) on canbohydrate metabolism of isolated fatty tissue and diaphragm of the rat].

Authors:  H DITSCHUNEIT; E F PFEIFFER; H G ROSSENBECK
Journal:  Klin Wochenschr       Date:  1961-01-15

3.  Progress in the Understanding and Treatment of Diabetes Mellitus.

Authors:  W J Butterfield
Journal:  Br Med J       Date:  1961-06-17

4.  A review of oral hypoglycemic agents.

Authors:  W S METZLER
Journal:  Can Med Assoc J       Date:  1962-08-18       Impact factor: 8.262

5.  Lactic acidosis with recovery in diabetes mellitus on phenformin therapy.

Authors:  J H Mestman; D S Pocock; A Kirchner
Journal:  Calif Med       Date:  1969-09

6.  [Plasma catecholamines in diabetes mellitus under treatment with N 1,n-butylbguanide].

Authors:  H G Lippmann; D Michaelis; E Köhler
Journal:  Klin Wochenschr       Date:  1965-09-01

7.  Efficiency and Safety of Chinese Herbal Medicine in the Treatment of Prediabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yanan Song; Haiyan Wang; Lingling Qin; Mei Li; Saiyue Gao; Lili Wu; Tonghua Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-14       Impact factor: 2.629

8.  The future of the diabetic child.

Authors:  M M BELMONTE
Journal:  Can Med Assoc J       Date:  1963-06-01       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.